← Eichor
Condition: Low To Intermediate Risk Prostate Carcinoma Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Low To Intermediate Risk Prostate Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-int
Phase 2 · 1 location(s) · Samsung Medical Center · NCT06461819Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Phase N/A · 1 location(s) · British Columbia Cancer Agency · NCT06200974A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06347705Two Fraction Prostate SBRT With DIL SIB
Phase 1 · 2 location(s) · NYU Langone Health · NCT05864196Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiothe
NA · 20 location(s) · Center Eugene Marquis · NCT03830788MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
NA · 1 location(s) · Mayo Clinic · NCT05438563Safety and Efficacy of Two-step Radical Prostatectomy
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT05722392
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.